Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Sales | 0 | 0 | 0 | 8 | 6 |
| Gross Profit | 0 | N/A | 0 | 8 | 6 |
| Operating Expenses | 10,997 | 316 | 23 | 185 | 1,149 |
| Operating Income | -10,997 | -316 | -23 | -177 | -1,143 |
| Interest Expense | 10 | 0 | 0 | 49 | 88 |
| Other Income | 1 | 0 | 0 | 0 | 229 |
| Pre-tax Income | -11,007 | -316 | -23 | -226 | -1,002 |
| Income Tax | 1 | N/A | 0 | N/A | 68 |
| Net Income Continuous | -11,008 | -316 | -23 | -226 | -1,070 |
| Net Income | $-11,008 | $-316 | $-23 | $-226 | $-1,070 |
| EPS Basic Total Ops | -10.79 | 0.00 | -119.75 | 0.00 | -0.04 |
| EPS Basic Continuous Ops | -10.21 | -0.35 | -119.75 | 0.00 | -0.04 |
| EPS Diluted Total Ops | -10.79 | 0.00 | -119.75 | 0.00 | -0.04 |
| EPS Diluted Continuous Ops | -10.21 | -0.35 | -119.75 | 0.00 | -0.04 |
| EBITDA(a) | $-10,997 | $-316 | $-23 | $-153 | $-1,110 |